Skip to main content

Table 2 Baseline clinical characteristics of pre-ART patients at GUH (September 11, 2008 to May 8, 2011)

From: Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study

Variables

Total, n (%)

In care, n (%)

LTFU, n (%)

P-value

Patient referral information (N= 1081)

   

0.118

  Within the hospital

796 (73.6)

518 (72.1)

278 (76.6)

 

  Outside the hospital

285 (26.4)

200 (27.9)

85 (23.4)

 

Disclosure of HIV+ status (N=1089)

   

0.174

  To spouse/family members only

616 (56.6)

423 (58.3)

193 (53.2)

 

  To relatives/friends only

86 (7.9)

61 (8.4)

25 (6.9)

 

  To spouse/family members & relatives/friends

35 (3.2)

23 (3.2)

12 (3.3)

 

  To no one

352 (32.3)

219 (30.2)

133 (36.6)

 

CD4 cell count/μl (N= 1076)

   

<0.001

  ≤ 200

611 (56.8)

505 (69.8)

106 (30.0)

 

  201-250

111 (10.3)

73 (10.1)

38 (10.8)

 

  251-300

75 (7.0)

50 (6.9)

25 (7.1)

 

  301-350

64 (5.9)

29 (4.0)

35 (9.9)

 

  > 350

215 (20.0)

66 (9.1)

149 (42.2)

 

WHO stage (N= 1070)

   

<0.001

  Stage I

257 (24.0)

137 (19.1)

120 (34.0)

 

  Stage II

194 (18.1)

126 (17.6)

68 (19.3)

 

  Stage III

446 (41.7)

332 (46.3)

114 (32.3)

 

  Stage IV

173 (16.2)

122 (17.0)

51 (14.4)

 

History of TB treatment (N= 1044)

   

0.058

  Yes

222 (21.3)

159 (23.0)

63 (17.9)

 

  No

822 (78.7)

533 (77.0)

289 (82.1)

 

Next appointment recorded (N= 1089)

   

<0.001

  Yes

784 (72.0)

710 (97.8)

74 (20.4)

 

  No

305 (28.0)

16 (2.2)

289 (79.6)